https://scholars.lib.ntu.edu.tw/handle/123456789/487263
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Yang P.-C. | en_US |
dc.contributor.author | JHE-CYUAN GUO | en_US |
dc.contributor.author | MIN-SHU HSIEH | en_US |
dc.contributor.author | CHIA-CHI LIN | en_US |
dc.contributor.author | CHIH-HUNG HSU | en_US |
dc.creator | Yang P.-C.;Guo J.-C.;Hsieh M.-S.;Lin C.-C.;Chih-Hung Hsu | - |
dc.date.accessioned | 2020-04-28T07:25:12Z | - |
dc.date.available | 2020-04-28T07:25:12Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 1556-0864 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042449118&doi=10.1016%2fj.jtho.2017.10.022&partnerID=40&md5=c1967c4c749456b3aa12186d94bf8ba0 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/487263 | - |
dc.publisher | Elsevier Inc | - |
dc.relation.ispartof | Journal of Thoracic Oncology | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | cisplatin; cyclophosphamide; doxorubicin; fluorouracil; folinic acid; gemcitabine; mismatch repair protein PMS2; MutL protein homolog 1; nivolumab; paclitaxel; programmed death 1 ligand 1; protein MSH6; tumor marker; monoclonal antibody; nivolumab; pembrolizumab; adult; cancer chemotherapy; cancer palliative therapy; cancer radiotherapy; cancer staging; case report; clinical article; computer assisted tomography; dyspnea; female; heart metastasis; hemoptysis; human; human cell; human tissue; immunohistochemistry; Letter; liver metastasis; lung gas exchange; lung hilus; lung metastasis; lymph node metastasis; lymphadenopathy; mediastinum metastasis; middle aged; multiple cycle treatment; pleura metastasis; priority journal; protein expression; repeated drug dose; salvage therapy; supraclavicular lymph node; thymus cancer; treatment response; lung tumor; salvage therapy; thymoma; tumor recurrence; Antibodies, Monoclonal, Humanized; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Nivolumab; Salvage Therapy; Thymoma | - |
dc.title | Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma | en_US |
dc.type | letter | en |
dc.identifier.doi | 10.1016/j.jtho.2017.10.022 | - |
dc.identifier.pmid | 29472056 | - |
dc.identifier.scopus | 2-s2.0-85042449118 | - |
dc.relation.pages | e36-e39 | - |
dc.relation.journalvolume | 13 | - |
dc.relation.journalissue | 3 | - |
item.openairecristype | http://purl.org/coar/resource_type/c_0857 | - |
item.openairetype | letter | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
crisitem.author.dept | Medical Oncology-NTUCC | - |
crisitem.author.dept | Pathology | - |
crisitem.author.dept | Pathology-NTUH | - |
crisitem.author.dept | Pathology-NTUCC | - |
crisitem.author.dept | Oncology-NTUH | - |
crisitem.author.dept | Oncology | - |
crisitem.author.dept | Medical Oncology-NTUCC | - |
crisitem.author.dept | Oncology-NTUH | - |
crisitem.author.dept | Cancer Administration and Coordination Center | - |
crisitem.author.orcid | 0000-0002-6689-9640 | - |
crisitem.author.orcid | 0000-0002-0594-3732 | - |
crisitem.author.orcid | 0000-0003-0495-973X | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。